b Toxin-antitoxin (TA) systems encoded in prokaryotic genomes fall into five types, typically composed of two distinct small molecules, an endotoxic protein and a cis-encoded antitoxin of ribonucleic or proteinaceous nature. In silico analysis revealed seven putative type I and three putative type II TA systems in the genome of the nonpathogenic species strain Staphylococcus equorum SE3. Among these, a MazEF system orthologue termed MazEF seq was further characterized. 5= rapid amplification of cDNA ends (RACE) revealed the expression and the transcriptional start site of mazE seq , indicating an immediately upstream promoter. Heterologous expression of the putative toxin-encoding mazF seq gene imposed growth cessation but not cell death on Escherichia coli. In vivo and in vitro, MazF seq was shown to cleave at UACAU motifs, which are remarkably abundant in a number of putative metabolic and regulatory S. equorum gene transcripts. Specific interaction between MazF seq and the putative cognate antitoxin MazE seq was demonstrated by bacterial two-hybrid analyses. These data strongly suggest that MazEF seq represents the first characterized TA system in a nonpathogenic Staphylococcus species and indicate that MazEF modules in staphylococci may also control processes beyond pathogenicity.
T oxin-antitoxin (TA) systems are small episomally or chromosomally encoded genetic modules found in bacteria or archaea (1) . TA systems typically consist of a small and stable toxic protein that can interfere with vital cellular functions and an unstable antitoxin, capable of inhibiting toxin activity (2) . Depending on the biochemical nature and mode of action of the antitoxin, five classes can be distinguished. Type I TA systems possess an RNA antitoxin that posttranscriptionally inhibits toxin activity via antisense regulation. TA systems of types II, IV, and V contain a small proteinaceous antitoxin that can render the toxin inactive either by protein-protein interaction, by cleavage of toxin mRNA, or by binding to the toxin's target structure. Type III TA systems (3) are characterized by an RNA antitoxin modulating toxicity in a posttranslational fashion (4) . TA systems of types III, IV, and V have so far been characterized in only one instance each (5-7), but orthologues of type I, type II, and supposedly also type III representatives are widespread among plasmids and chromosomes of prokaryotes (3, 8) . According to toxin sequence homology, at least 10 families of type II TA systems can be distinguished (4, (9) (10) (11) . The genome of the notorious pathogen Staphylococcus aureus possibly bears a number of type I TA systems, from which one candidate has recently been characterized (12) . Three type II TA systems, MazEF sa , YefM-YoeB-sa1, and YefM-YoeB-sa2, have been validated, and all of them encode endoribonucleases. The sequence-specific RNA cleavage activity of MazF sa can be inhibited by its cognate antitoxin MazE sa , which, in turn, is subject to degradation by the ClpPC proteolytic system (13) . Transcriptionally, the mazEF sa genes are downregulated by the alternative sigma factor B and induced by the global regulator sarA (14) , in contrast to Escherichia coli, where mazEF is negatively autoregulated (15) . Overexpression of mazF sa was found to result in a growth defect in S. aureus (16, 17, 19) . Unlike MazF sa , endoribonuclease activity of YoeB-sa1 and YoeB-sa2 is stimulated by ribosome association to cleave mRNAs adjacent to the start codon (20) . Expression of both yefM-yoeB-sa paralogues is transcriptionally autoregulated but is also increased by certain antibiotic stresses (14) . Research on TA systems in staphylococci has to date been confined to S. aureus, neglecting at least 41 further species of this genus (21) . Staphylococci form a distinct monophyletic group (which can further be divided into different species and cluster groups), also comprising a number of nonpathogenic species (22) , such as Staphylococcus equorum, a member of the Staphylococcus saprophyticus cluster and thus relatively distantly related to S. aureus. S. equorum was originally isolated from the skin of healthy horses (23) and was later also found on the surface of red-smear cheese. Some strains are able to inhibit the growth of the food-borne pathogen Listeria monocytogenes by producing the macrocyclic, nonribosomally synthesized peptide antibiotic micrococcin P 1 (24, 25) . It has therefore been suggested to use such S. equorum strains in cheese starter cultures to prevent growth of L. monocytogenes and other undesired bacteria. A genome-sequencing program for strain S. equorum SE3 has recently been started (F. Götz and R. Rosenstein, unpublished data). In this study, we performed extensive in silico screening for TA systems in the S. equorum SE3 raw, partially assembled sequencing data, revealing a number of putative type I and type II TA systems. Among these, a gene pair dubbed mazEF seq was genetically and biochemically characterized and yielded strong evidence for a first characterized functional TA system encoded in the S. equorum genome. We determined the transcriptional starting point of the mazEF seq locus and provide evidence for a toxic effect of mazF seq expression and for in vivo interaction of MazF seq and MazE seq in E. coli. It is shown that the purified putative toxin endolytically cleaves RNA in a sequence-specific manner, as it also does upon heterologous expression in vivo. Finally, we identified coding sequences that might posttranscriptionally be controlled by MazF seq -dependent cleavage due to unusually high relative abundances of respective target sites. tides were ordered from Biomers (Ulm, Germany) and Integrated DNA Technologies (Coralville, IA).
Bacterial strains, plasmids, and growth conditions. The E. coli strains BL21(DE3) (38) , DH5␣ (39), BW25113 (40) , and BTH101 (41) (Euromedex, Souffelweyersheim, France), as well as S. equorum SE3 (kindly provided by F. Götz), were used in this study (Table 1) . E. coli cells were grown either in LB or, whenever sugar-sensitive inducible plasmids were used, in M9 minimal medium (44) supplemented with 0.2% (wt/ vol) thiamine, 0.2% (wt/vol) Casamino Acids (CAA), and either 0.4% (wt/vol) glucose or 0.2% (vol/vol) glycerol as a carbon source. During the BACTH bacterial two-hybrid experiments (see below), cells were grown on LB agar plates supplemented with X-Gal (5-bromo-4-chloro-3-indolyl-␤-D-galactopyranoside) and IPTG (both from Carl Roth, Karlsruhe, Germany) at final concentrations of 40 g/ml or 0.5 mM, respectively. S. equorum was grown in basic medium (BM) (45) . All cultures were grown with shaking (150 rpm) in baffle flasks at 37°C with aeration. Antibiotics were used where appropriate at the following concentrations: 100 g/ml ampicillin, 25 g/ml chloramphenicol, and 50 g/ml kanamycin.
Molecular cloning and isolation of nucleic acids. In general, cloning was carried out using standard protocols. E. coli cells were made chemically competent by RbCl treatment (46) . Plasmids and DNA fragments were isolated or purified using standard kits from Sigma-Aldrich (Munich, Germany), Peqlab (Erlangen, Germany), and Qiagen (Hilden, Germany) according to the manufacturers' protocols. Genomic DNA of staphylococci was obtained either by breaking cells with lysostaphin (15 g/ml for 90 min) and NaClO 4 treatment and chloroform-isoamyl alcohol extraction as described previously (47, 48) or by using the InstaGene kit (Bio-Rad, Munich, Germany). The nucleotide sequence of the S. equorum mazEF seq locus can be found under the GenBank accession number KC020193. Sequencing of cloned products was done at GATC (Constance, Germany) and Macrogen Corp. (New York, NY), and results were confirmed using Lasergene SeqMan (DNAStar, Madison, WI).
Construction and growth analysis of E. coli DH5␣(pASK-IBA3 mazF seq ). mazF seq , including its native ribosome-binding site (RBS), was PCR amplified from S. equorum SE3 genomic DNA (GenBank accession number KC020193) using the primers mazF_f and mazF_r (all oligonucleotides are listed in Table S1 in the supplemental material). The PCR product was digested with BglII and NcoI and ligated with the ATc-inducible vector pASK-IBA3 cut with NcoI and BamHI, yielding pASK-IBA3-mazF seq , which was used to transform E. coli DH5␣. Resulting strains carrying pASK-IBA3 with or without mazF seq were grown overnight in LB, and cultures from both strains were used to inoculate two flasks containing 17 ml of LB each to an optical density at 578 nm (OD 578 ) of 0.07. Cells were cultivated with shaking at 37°C, and 60 min later, ATc (0.4 M final concentration) was added to one flask of each strain. Growth was monitored on an hourly basis by determining both OD 578 values (measured as 10-fold or 20-fold dilutions, where necessary) and CFU counts. To this end, samples were 10-fold serially diluted from 10 0 to 10 Ϫ7 in sterile saline solution (0.85% [wt/vol] NaCl) and plated on LB plates containing ampicillin. After 14 to 16 h of incubation at 37°C, the numbers of colonies were counted.
BACTH two-hybrid analysis of MazE seq -MazF seq interaction in vivo. The bacterial adenylate cyclase-based two-hybrid system (BACTH; Euromedex, Souffelweyersheim, France) functions by fusing two putative binding partners to the Bordetella pertussis adenylate cyclase (CyaA) fragments T18 and T25. These form an active enzyme only when in close proximity, providing evidence for interaction of the fused proteins. The cyclic AMP (cAMP)-dependent activation of lactose-utilizing genes is visualized by blue colonies on X-Gal-containing medium. We cloned maz-E seq in two ways to the T18-encoding fragment, to obtain N-and C-terminal translational fusions using the high-copy-number BACTH vectors pUT18 (mazE seq N terminally fused) and pUT18C (C-terminal fusion). Products amplified by PCR using the primers mazE_bacth_f and mazE_bacth_r were cloned with the restriction enzymes BamHI and XmaI. Similarly, mazF seq was cloned in frame with the T25 open reading frame (ORF) into the low-copy-number BACTH vector pKT25 (C-terminal fusion) using the primers mazF_bacth_f and mazF_bacth_r and restriction enzymes as described above. Constructs were confirmed by sequencing, and the pUT18-, pUT18C-, and pKT25-derived vectors were used to consecutively transform strain E. coli BTH101. Single colonies of cells containing both plasmids (one each of the pUT and of the pKT series) were streaked onto LB-X-Gal-IPTG plates to provide evidence for proteinprotein interaction. As negative controls, strains that harbor a plasmid containing the T18 fragment alone with either a plasmid containing only the T25 fragment or the T25 fragment translationally fused with a leucine zipper component (from N to C terminus, T25-zip) were used. In addition, the genes yefM-seq1 and yoeB-seq1 from S. equorum were PCR amplified using the primer pairs yefM1_bacth_f and yefM1_bacth_r or yoeB1_bacth_f and yoeB1_bacth_f and cloned via BamHI/XmaI in frame with the adenylate cyclase-encoding fragments into the vector(s) pUT18/ pUT18C or pKT25, respectively. These yefM-seq1 and yoeB-seq1 constructs were used to transform cells containing the appropriate corresponding mazE seq or mazF seq constructs to obtain additional negative controls. None of these showed coloring on LB-X-Gal-IPTG agar plates, whereas the interaction of the two leucine zipper components (T18-zip and T25-zip) of the positive control was clearly visible as a blue coloration.
Overexpression and purification of (His) 6 -tagged MazF seq . mazF seq was PCR amplified from genomic DNA using primers mazFhis_r and mazFhis_f, introducing codons for a C-terminally fused (His) 6 tag, and the product was cloned into the IPTG-and cold shock-inducible vector pColdIII via NdeI and BamHI. E. coli BL21(DE3) carrying the resulting vector pColdIII mazF seq was grown at 37°C in M9 medium supplemented with Casamino Acids and glucose to an OD 600 of 0.5. Cultures were then induced by 5-min incubation on ice and IPTG (0.5 mM final concentration), grown subsequently at 15°C, and lysed after 24 h using a French press (Thermo Scientific, Waltham, MA). MazF seq -(His) 6 was purified using a Ni-NTA resin according to the manufacturer's protocol (Qiagen, Valencia, CA), dialyzed twice (20 mM phosphate buffer, 5 mM dithiothreitol [DTT], 100 mM NaCl, 0.5 mM EDTA), and stored in this buffer at Ϫ20°C in aliquots.
Elucidation of MazF seq target specificity by primer extension analysis. In vitro primer extension experiments were done as described previously (19) . Briefly, 800 ng of MS2 phage RNA (NCBI accession number NC_001417.2, purchased from Roche, Indianapolis, IN) was incubated with 1 g of purified MazF seq -(His) 6 in 10 mM Tris-HCl (pH 7.8), also containing 0.5 l RNase inhibitor (Roche, Indianapolis, IN) and 32 g CspA for 30 min at 37°C, in a total reaction volume of 10 l. CspA, a cold shock protein and RNA chaperone from E. coli, was purified as previously described (49) . Prior to use, primers were 5= labeled using a T4 polynucleotide kinase and [␥-
32 P]ATP. Primer extension reactions were carried out with added MS2 RNA fragments, AMV RT, and labeled primers for 1 h at 47°C. The extension reaction was terminated by the addition of 6 l of stop solution 1 (95% formamide, 20 mM EDTA, 0.05% bromophenol blue, and 0.05% xylene cyanol EF), incubation for 2 min at 95°C, and storage on ice for 5 min. After being heated to 90°C for 5 min, samples were electrophoresed on a 6% polyacrylamide gel with 8 M urea, which was subsequently dried for 2 h in a gel vacuum dryer before an X-ray film (Kodak, Rochester, NY) was exposed for 20 to 48 h. In vivo primer extension assays were performed according to the literature (20, 50) , but instead of using 32 P labeling, primers were ordered with a DY-681 (Dyomics, Jena, Germany) infrared dye modification at the 5= end. Plasmid pBAD33 SD mazF seq was constructed by cloning PCR-amplified mazF seq (primers mazF_BAD_f and mazF_BAD_r) into pBAD33 via SacI and XbaI. E. coli BW25113 cells containing pBAD33 SD mazF seq or the empty pBAD33 vector were grown in 250-ml flasks containing 100 ml BM to an OD 578 of 0.6. The cells were then split, and to one flask of each construct, arabinose was added to a final concentration of 0.2% (wt/vol). After 40 min, 12 ml of culture from each flask was harvested and the cells were broken by treatment with glass beads (Roth, Karlsruhe, Germany) and a tissue lyser (Thermo Savant; FastPrep FP120 Bio101) twice for 20 s. Total RNA was extracted from the lysate using TRIzol (Ambion, Life Technologies, Darmstadt, Germany) according to the manufacturer's protocol, the RNA pellets were dissolved in THE RNA storage solution (Ambion, Life Technologies, Darmstadt, Germany), and the concentration was determined by NanoDrop measurement. Reverse transcription was conducted in the presence of 16 g total RNA, 1 pmol DY-681-labeled primer (OmpF_ec or TufA_ec), 10 mmol deoxynucleoside triphosphates (dNTPs), 10 U AMV RT (Roche), 1ϫ AMV RT buffer, and 4 U of SUPERase-In RNase inhibitor in a total volume of 10 l for 60 min at 47°C and stopped by the addition of 6 l stop solution 2 (95% formamide, 10 mM EDTA, 0.05% bromophenol blue). Sequencing ladders were generated from genomic DNA prepared from E. coli BW25113 pBAD33 cells using the Thermo Sequenase fluorescently labeled primer cycle sequencing kit with 7-deaza-dGTP (GE Healthcare, Freiburg, Germany) and the primers OmpF_ec and TufA_ec. All samples were heated for 2 min at 95°C and then loaded onto a 25 cm 8M urea, 10% polyacrylamide gel and run on a Li-Cor Long ReadIR 4200 system (Lincoln, NE) using the IRD700 channel according to the manufacturer's recommendations.
For RNA oligonucleotide digestion tests, ␥-32 P-labeled fragments were subjected either to digestion by purified MazF seq -(His) 6 or to chemical hydrolysis, to provide a molecular weight standard ladder for electrophoresis. In a total volume of 10 l, 0.5 l RNase inhibitor, 0.25 g MazF seq -(His) 6 , 1 l Tris-HCl (pH 7.8, 100 mM), and 0.5 l radioactively labeled primer (10 pmol/l) were mixed and incubated for 30 min at 37°C for enzymatic cleavage by MazF seq -(His) 6 . The reaction was stopped as before. A nucleotide ladder was created by mixing 2 l of labeled RNA with 1 l NaOH (1 M) and 7 l DEPC-treated H 2 O and incubating the mixture for 1 min at 75°C followed by terminating the reaction with 40 l stop buffer. The samples were loaded onto a 20% SDS gel with 8 M urea and further processed as described above.
Transcription start site determination by 5= RACE. An S. equorum culture was grown in BM to an OD 578 of 1.4, and the RNA was isolated as described above (in vivo primer extension). 5= RACE was essentially done as described before (51) . Specifically, 7.5 g of total RNA was incubated with 12.5 U of tobacco acid pyrophosphatase (TAP), 20 U of SUPERase-In (Ambion, Life Technologies, Darmstadt, Germany), and 1ϫ TAP buffer for 1 h at 37°C. This modified RNA was extracted with acidic P/C/I solution, ethanol precipitated, dissolved in 55 l DEPC-treated ddH 2 O, and incubated with 500 pmol of an RNA adapter fragment (see Table S1 in the supplemental material) at 95°C for 5 min. Ligation of cellular RNA molecules with the RNA adapter was done for 90 min at 16°C with 50 U of T4 RNA ligase I, 20 U of SUPERase-In, 1ϫ T4 RNA ligase buffer, 1 mM ATP, and 1 mg/ml bovine serum albumin (BSA) in a total volume of 80 l. The ligated RNA was phenol-chloroform extracted and ethanol precipitated as before and resuspended in 10 l DEPC-treated ddH 2 O. Five microliters was used for reverse transcription by using the Roche first-strand cDNA synthesis kit for RT-PCR (containing AMV RT) with a primer specific for mazE seq (mazE-RACE-outer) in a total volume of 20 l. One microliter of 10-fold-diluted cDNA was PCR amplified using 1 M (each) primers specific for the adapter (RACE-PCR) and for mazE seq (mazE-RACE-inner), 1 mM dNTPs, 1ϫ Taq buffer E, and 5 U Taq polymerase (Genaxxon, Ulm, Germany) in a 50-l reaction mixture. Amplification of cDNA was confirmed on a 2% agarose gel, and 2 l of the PCR product was used for ligase-and restriction-independent TOPO cloning followed by transformation of One Shot chemically competent E. coli Top10 cells (Invitrogen/ Life Technologies). Sequencing of the resulting plasmids allowed determination of the transcriptional start site of mazEF seq .
Analysis of TACAT sequence abundance in the S. equorum SE3 genome. A screen for TACAT motifs in coding sequences (CDSs) of the S. equorum SE3 genome, including an assessment of stochastic or cumulative occurrence, was performed as described previously (19, 52) . Briefly, the probability P of a CDS containing K (actual number) or fewer TACAT sites is dependent on the base composition and length (L) and was calculated as follows:
The expected number of TACAT sites is p(L Ϫ 4) where p, the probability of the pentad sequence occurring in a CDS stochastically, is p ϭ (% of A) 2 (% of T) 2 (% of C) 2 . The complete set of 2,581 possible CDSs of S. equorum SE3 was exported from an automatically annotated data set using GenDB (53) and passed on to a custom Perl script (the source code is available upon request) calculating P for each CDS and sorting the results in a descending order.
RESULTS AND DISCUSSION
In silico analysis indicates several putative type I and type II TA systems in the genome of Staphylococcus equorum. In this study, we were interested in mining the genome of the nonpathogenic, food industry-relevant bacterium S. equorum SE3 for putative TA systems, for two main reasons. First, it has been proposed that the abundance of TA systems may be higher in free-living organisms than in host-associated species (8) , which would suggest a greater number of such systems in S. equorum than in S. aureus. Second, one of the TA systems of S. aureus was suggested to regulate pathogenicity factors (19) , which raises the question whether nonpathogenic staphylococci also possess TA systems and, if so, what their functions might be. In order to identify putative type I TA systems in the raw genome of S. equorum SE3, we first conducted manual BLAST searches. Using the putative S. saprophyticus type I toxin Fst described by Fozo et al. (26) as a query revealed five possible homologues in S. equorum (Fig. 1) . Respective systems have previously been suggested to reside on a number of other staphylococcal plasmids and chromosomes (54, 55) but have, with one recent exception (12) , not been characterized yet. To assess if the putative antitoxin RNAs of these systems may be transcribed, we performed an in silico prediction of promoters by the detection of destabilized regions (33) . For three of the five systems, a region with low stability was detected, which complements the presence of Ϫ10 and Ϫ35 box motifs (Fig. 1) . The putative antitoxin RNAs do not overlap the coding sequence of the assumed toxin. Therefore, we performed an in silico RNA-RNA interaction prediction between the antitoxin RNAs and the toxin mRNAs. For all five pairs of RNAs, a stable interaction was predicted with free energy values ranging from Ϫ16.6 to Ϫ23.5 kcal/mol (see Table S2 in the supplemental material). In all cases, the predicted interaction site partly covers the putative ribosome-binding site of the toxin mRNA, providing evidence for a possible regulatory role of the candidate antitoxin RNA. In addition, two possible TxpA/RatA type I TA systems were identified, sharing distinct features with putative staphylococcal systems (26) . To collect further evidence that the candidate antitoxin RNAs of these systems are functional, we created a ClustalW sequence alignment of the two antitoxin RNAs with the RatA homologue in S. aureus (56) . According to a prediction by the program RNAz (27) , the aligned RNAs contain a stable conserved secondary structure (classifier P value, 0.99). This suggests that the two putative antitoxin RNAs identified in S. equorum carry out a similar function. Manual BLAST searches for the two representatives of type IV and type V TA systems YeeU-CbtA (6) and GhoST (7) yielded no apparent homologues in S. equorum.
For the revelation of putative type II TA systems in the S. equorum SE3 genome, the publicly accessible online tools RASTA Bacteria (34) and TADB (35) were used. This approach yielded three candidate loci bearing two distinct putative yefM-yoeB systems (Fig. 2) and an apparent mazEF orthologue (see below), which reflects the complete set of validated type II TA systems in S. aureus (16, 19, 20) . Thus, we identified a total of 10 putative TA systems in the S. equorum SE3 genome (summarized in Table 2 ), seven of which belonged to type I and three to type II TA systems. The two putative yefM-yoeB paralogues are clearly homologous to the yefM-yoeB-sa1 and -sa2 systems from S. aureus (20) , and the N315 with their S. equorum (seq) SE3 homologues. Sequences were aligned using MAFFT (63) , and residues were shaded according to their BLOSUM62 score in BioEdit (37) . mazEF TA System from Staphylococcus equorum degree of similarity to S. aureus counterparts was even more pronounced in the case of the putative mazEF system (16), as detailed in Fig. 3 . An examination of the adjacent genomic context surrounding the candidate mazEF genes also revealed an identical gene synteny in S. equorum and S. aureus. The respective gene pair was hence termed mazEF seq and was further experimentally characterized.
P mazE seq lies adjacent to the mazEF seq locus. To provide evidence about the expression of the mazEF seq genes and their transcriptional start point(s), 5= RACE was conducted using total RNA isolated from exponential-phase S. equorum SE3 cells. Sequencing of three independent plasmids containing cDNA from reverse transcription revealed an identical fragment, unambiguously indicating a single transcriptional starting point (TSP) 50 bp upstream of the mazE seq start codon (Fig. 3) . Starting at the seventh base preceding the TSP, the sequence TAGTCA(N) 17 TATTAT was found, likely representing the Ϫ35 and Ϫ10 sites of a Adependent promoter separated by a stretch of optimal distance (58) . The presumable Ϫ35 hexamer was flanked by almost-perfect inverted repeats of the sequence AAAAT(A)GTA, harboring a putative binding site for the S. aureus global regulator SarA (59) . Starting at the 34th base downstream of the TSP and located eight bases upstream of the start codon, a TGGAGGT stretch represents the probable ribosome-binding site for mazE seq . These features reflect almost identical cis elements and transcriptional start sites of the orthologous S. aureus system (14, 18) .
Heterologous overexpression of MazF seq in E. coli impairs growth. Tools for the genetic manipulation of S. equorum have not been established to date. Therefore, the putative toxin-encoding gene mazF seq was cloned into the tetracycline-inducible E. coli cloning vector pASK-IBA3. Induction of mazF seq expression in E. coli resulted in an up to 10-fold reduction of OD 578 values in comparison to those of noninduced strains and those carrying the empty plasmid during the course of the experiment (Fig. 4A ). An Genetic organization of the mazEF-sigB locus in S. equorum SE3. Gene synteny is identical in S. aureus COL (not shown). (Bottom) Transcriptional start point of mazE in S. equorum SE3 (seq) compared to S. aureus COL (sa) (14, 18) . Letters "a" and "b" and the corresponding arrows indicate inverted repeats surrounding the Ϫ35 region, putatively representing SarA binding sites. Repeat "a" contains a one-base insertion (gray "A") in comparison to repeat "b". "ϩ1" indicates the transcriptional starting point, which is 50 bp upstream of the mazE seq start codon.
observation of concomitant CFU values revealed that the expression of MazF seq exerted a bacteriostatic but not a bactericidal effect on E. coli, as reflected by rather constant colony counts up to 8 h after induction (Fig. 4B ). This observation is in agreement with results from the work of Syed et al. (60) , when expression of Streptococcus mutans mazF induced growth arrest in E. coli. Of note, Fu and colleagues (16) reported bacteriostatic effects upon mazF sa overexpression in S. aureus. In our experiments, heterologous overexpression of mazF seq in S. aureus from inducible plasmids did not lead to a growth defect (unpublished results). This was possibly due to cross-interaction of the S. aureus antitoxin orthologue with the S. equorum toxin or due to weaker expression than that in the previous study, in which a different induction system for mazF sa had been used (16) . MazF seq interacts with MazE seq in vivo. To check for proteinprotein interaction between MazE seq and MazF seq , a bacterial twohybrid analysis using the BACTH system was conducted (41) . It makes use of two fragments of adenylate cyclase (T18 and T25) that form an active enzyme only when in close proximity, thus providing evidence for interaction of the fused proteins. Catabolite gene activator protein (CAP)/cAMP-dependent activation of lactose utilization in E. coli is visualized by blue colonies on X-Galcontaining medium. Pronounced blue coloring was evident with strains producing MazF seq C terminally fused to the T25 fragment with either N-or C-terminally fused MazE seq -T18, suggesting that MazF seq is bound by MazE seq in vivo (Fig. 5) . This adds to data from the work of Fu et al. (16) (62) . Extensive negative controls yielded colorless colonies, ruling out unspecific ␤-galactosidase activation observed with the mazE-mazF plasmid couples.
MazF seq is a sequence-specific endoribonuclease that preferentially cleaves within the UACAU motif. To determine the catalytic activity and sequence specificity of MazF seq , an affinitypurified C-terminally hexahistidine-tagged fusion protein (Fig. 6A) was incubated with 3.5-kb MS2 phage RNA in the presence of CspA in vitro, followed by primer extension reactions. In total, seven restriction sites could be determined (Fig.  6B) . In five of these cases, UACAU sites were cleaved, mainly after and occasionally before the first uracil. Of note, one out of six UACAU motifs in MS2 RNA appeared to be unaffected (Fig.  6B , C, and D; not all data are shown). In addition, cleavage was observed at the one-base aberrant sequence UٙCCAU, as well 
FIG 5
Bacterial two-hybrid study to confirm the specific in vivo interaction of MazF seq with MazE seq . Negative controls (sectors 1 to 6), also including components of the putative YefM-YoeB-seq1 TA system, did not show blue coloration, whereas the leucine zipper positive control (sector 9) yielded colored colonies. Strains BTH101(pUT18-mazE pKT25-mazF) (sector 7) and BTH101(pUT18C-mazE pKT25-mazF) (sector 8) showed considerable blue coloration, indicating protein-protein interaction.
as at CGٙCٙACU (Fig. 6B) . To rule out sequence specificity extending the five-base motif, synthetic RNA oligonucleotides containing UACAU sites flanked by different combinations of bases were treated with MazF seq . Restrictions were observed at UACAU sequences preceded by either U or C at the 5= end and trailed by either C, A, or G at the 3= end (Fig. 6B) . Specific MazF seqdependent restriction in all of these cases suggested that the main MazF seq recognition site is the pentad sequence UACAU, in agreement with the S. aureus orthologue (19) . Regarding the high degree of similarity between MazF seq and MazF sa , this finding is not unexpected; instead, it speaks in favor of UACAU as the major restriction site of both staphylococcal MazF RNA interferases, after an initial report on MazF sa cleavage specificity had reported on a slightly different motif (16) . In agreement with studies by Zhu et al. (19, 52) , cleavage of some UACAU sites by MazF seq in vitro was enhanced in the presence of CspA, evidently due to the removal of higher RNA structures that might impede access of MazF seq to the target site.
We note that the affinity-purified fraction of the MazF seq protein had not been purified to homogeneity (Fig. 6A) . To confirm that the RNase activity observed in the in vitro primer extension assays was solely conferred by MazF seq , in vivo primer extensions were conducted. For this, total RNA was extracted from E. coli BW25113 cells in which MazF seq had been induced before. Primer extensions were done using the mRNAs of ompF and tufA, which are confirmed targets for MazF from Firmicutes expressed in E. coli (50) . Judging from respective RNA preparations, defined bands were visible at the UACAU sites directly after the first U in the in vivo primer extensions ( Fig. 7A and B) . These signals were missing in the absence of MazF seq , backing up the results from the in vitro primer extension assays and suggesting that the specific cleavage of the mRNA is due to the activity of the MazF seq protein. 6 treatment with different radioisotope-labeled primers. In both cases, RNA restriction (arrowheads) was more pronounced in the presence of CspA. Restriction occurred before or after the 5= uracil of the recognition sequence. Labeling of the sequencing ladder is complementary to the chain terminator dideoxynucleoside triphosphate (ddNTP) used (e.g., ddATP for U lane, etc.). (E) Synthetic RNA oligonucleotides containing the UACAU sequence (preceded and trailed by different bases) were incubated with purified MazF seq -(His) 6 to verify that the recognition site is confined in length to the pentad sequence UACAU. All four test oligonucleotide RNAs were cut by MazF seq -(His) 6 , with the resulting RNA fragments indicated by arrowheads.
FIG 7
In vivo primer extension experiments for MazF seq carried out with different primers (OmpF_ec and TufA_ec) and RNA templates prepared from E. coli BW25113 carrying pBAD33 (empty) or carrying pBAD33 SD mazF seq (mazF seq ). Lanes 1, empty Ϫ Ara; lanes 2, empty ϩ Ara; lanes 3, mazF seq Ϫ Ara; lanes 4, mazF seq ϩ Ara. Reverse transcriptions from the RNA of BW25113 cells with either the empty pBAD33 vector or the uninduced MazF seq construct revealed no cleavage at the UACAU sites, whereas mRNA cleavage at UACAU could be observed in the presence of MazF seq (arrowheads). The result for only one of the two UACAU sites in tufA RNA is shown here. The sequencing ladder was done from E. coli BW25113 genomic DNA, and the figure inscription represents the bases from the template strand, not the ddNTPs used (e.g., the T lane was created with ddATP etc.).
Elevated local concentrations of MazF seq target sites in coding sequences. To screen for mRNAs that might be particularly susceptible to MazF seq cleavage in S. equorum, a statistical analysis of the occurrences of the UACAU motif in its 2,581 possible CDSs was conducted as previously described (19, 52) . According to the equation detailed in Materials and Methods, Table 3 summarizes the top 10 candidate sensitive MazF seq target genes and their closest S. aureus orthologues. A number of the putative target CDSs code for hypothetical proteins, whereas the others are likely involved in catabolism of sugars, amino acids, and lipids. Intriguingly, the CDS of rsbV, putatively coding for an anti-anti-B factor, might also have a higher susceptibility to MazF seq , due to the unusually high abundance of UACAU sites (three copies within 327 bases). Assuming negative regulation of mazEF seq expression by B as in S. aureus (14) , the conceivable cleavage of rsbV by MazF seq would add a coherent second mode of mazEF seq control. As in S. aureus (18) , a lack of RsbV would arguably result in unbound anti-B factor RsbW, which might thus complex with B . This would abolish the repressive effect of B on mazEF seq expression to impose a positive feedback loop. These assumptions warrant further studies, which may also confirm target genes of MazF seq and unravel the regulation of mazEF seq activity.
Conclusions. To our knowledge, this study describes the first characterization of a putative TA system in a nonpathogenic Staphylococcus species. We show that in S. equorum SE3, the mazEF seq genes are expressed and are highly similar in sequence, length, position, synteny, and TSP to their S. aureus counterparts. Although both the trigger(s) and the function(s) of the MazEF system in S. equorum remain enigmatic to date, regulation of staphylococcal pathogenicity, as proposed by Zhu et al. (19) , is probably not the sole function of this TA system, which has orthologues in at least seven further Staphylococcus species (our unpublished results). In the future, it will be interesting to reveal the instances of activity control, and indeed, besides sigB S. equorum also possesses sarA, clpP, and clpC orthologues (unpublished results) possibly involved in regulating MazE seq abundance. 
